Literature DB >> 24343233

Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers.

Enrico Premi1, Anna Formenti1, Stefano Gazzina1, Silvana Archetti2, Roberto Gasparotti3, Alessandro Padovani1, Barbara Borroni1.   

Abstract

IMPORTANCE: Granulin (GRN) mutations represent one of the most frequent genetic causes of inherited frontotemporal dementia. The study of asymptomatic carriers of GRN Thr272fs mutation (aGRN+) provides a unique opportunity to study the natural history of the disease and the role of modulating factors on disease onset. It has been demonstrated that the TMEM106B polymorphism is associated with GRN-related frontotemporal dementia and affects age at onset in GRN mutation carriers.
OBJECTIVE: To ascertain whether TMEM106B genetic status modulates GRN disease by evaluating resting-state functional connectivity in aGRN+ individuals according to TMEM106 genetic variation. DESIGN, SETTING, AND PARTICIPANTS: Academic tertiary referral center for neurodegenerative disorders in 17 asymptomatic carriers of aGRN+ and 14 healthy controls. MAIN OUTCOMES AND MEASURES: Changes in resting-state functional connectivity, focusing on the default mode network, ventral and dorsal salience networks, executive network, frontoparietal networks, and attentive network and the effect of TMEM106B genotypes in aGRN+ participants and healthy controls (statistical nonparametric mapping).
RESULTS: aGRN+ participants showed decreased brain connectivity within the left frontoparietal network and increased connectivity in the executive network compared with healthy controls. The TMEM106B at-risk polymorphism (T/T) was associated with decreased connectivity within the ventral salience network (ie, middle frontal gyrus) and the left frontoparietal network (ie, left precuneus). CONCLUSIONS AND RELEVANCE: This study suggests that the TMEM106B polymorphism modulates brain connectivity in aGRN+ individuals, with additional damage of the ventral salience network and left frontoparietal network observed. Genotyping TMEM106B is of importance in aGRN+ individuals for prognostic purposes and to assess early brain damage.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24343233     DOI: 10.1001/jamaneurol.2013.4835

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  21 in total

1.  The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint.

Authors:  Enrico Premi; Vince D Calhoun; Matteo Diano; Stefano Gazzina; Maura Cosseddu; Antonella Alberici; Silvana Archetti; Donata Paternicò; Roberto Gasparotti; John van Swieten; Daniela Galimberti; Raquel Sanchez-Valle; Robert Laforce; Fermin Moreno; Matthis Synofzik; Caroline Graff; Mario Masellis; Maria Carmela Tartaglia; James Rowe; Rik Vandenberghe; Elizabeth Finger; Fabrizio Tagliavini; Alexandre de Mendonça; Isabel Santana; Chris Butler; Simon Ducharme; Alex Gerhard; Adrian Danek; Johannes Levin; Markus Otto; Giovanni Frisoni; Stefano Cappa; Sandro Sorbi; Alessandro Padovani; Jonathan D Rohrer; Barbara Borroni
Journal:  Neuroimage       Date:  2019-02-01       Impact factor: 6.556

2.  TMEM106B: a strong FTLD disease modifier.

Authors:  Yuetiva Deming; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2014-02-01       Impact factor: 17.088

3.  Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study.

Authors:  Qin Chen; Bradley F Boeve; Matthew Senjem; Nirubol Tosakulwong; Timothy Lesnick; Danielle Brushaber; Christina Dheel; Julie Fields; Leah Forsberg; Ralitza Gavrilova; Debra Gearhart; Jonathan Graff-Radford; Neill Graff-Radford; Clifford R Jack; David Jones; David Knopman; Walter K Kremers; Maria Lapid; Rosa Rademakers; Eliana Marisa Ramos; Jeremy Syrjanen; Adam L Boxer; Howie Rosen; Zbigniew K Wszolek; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2019-12-12       Impact factor: 4.673

4.  Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia.

Authors:  Gianina Toller; Yann Cobigo; Peter A Ljubenkov; Brian S Appleby; Bradford C Dickerson; Kimiko Domoto-Reilly; Jamie C Fong; Leah K Forsberg; Ralitza H Gavrilova; Nupur Ghoshal; Hilary W Heuer; David S Knopman; John Kornak; Maria I Lapid; Irene Litvan; Diane E Lucente; Ian R Mckenzie; Scott M McGinnis; Bruce L Miller; Otto Pedraza; Julio C Rojas; Adam M Staffaroni; Bonnie Wong; Zbigniew K Wszolek; Brad F Boeve; Adam L Boxer; Howard J Rosen; Katherine P Rankin
Journal:  Neurology       Date:  2022-05-18       Impact factor: 11.800

Review 5.  Primary progressive aphasia and the evolving neurology of the language network.

Authors:  M-Marsel Mesulam; Emily J Rogalski; Christina Wieneke; Robert S Hurley; Changiz Geula; Eileen H Bigio; Cynthia K Thompson; Sandra Weintraub
Journal:  Nat Rev Neurol       Date:  2014-09-02       Impact factor: 42.937

Review 6.  What we know about TMEM106B in neurodegeneration.

Authors:  Alexandra M Nicholson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2016-08-20       Impact factor: 17.088

Review 7.  Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy.

Authors:  Michela Pievani; Nicola Filippini; Martijn P van den Heuvel; Stefano F Cappa; Giovanni B Frisoni
Journal:  Nat Rev Neurol       Date:  2014-10-07       Impact factor: 42.937

8.  Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia.

Authors:  Raffaele Ferrari; Mario Grassi; Francesca Graziano; Fernando Palluzzi; Silvana Archetti; Elisa Bonomi; Amalia C Bruni; Raffaele G Maletta; Livia Bernardi; Chiara Cupidi; Rosanna Colao; Innocenzo Rainero; Elisa Rubino; Lorenzo Pinessi; Daniela Galimberti; Elio Scarpini; Maria Serpente; Benedetta Nacmias; Irene Piaceri; Silvia Bagnoli; Giacomina Rossi; Giorgio Giaccone; Fabrizio Tagliavini; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Andrew Singleton; John Hardy; Parastoo Momeni; Alessandro Padovani; Barbara Borroni
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence.

Authors:  Corey T McMillan; Jenny Russ; Elisabeth M Wood; David J Irwin; Murray Grossman; Leo McCluskey; Lauren Elman; Vivanna Van Deerlin; Edward B Lee
Journal:  Neurology       Date:  2015-03-20       Impact factor: 9.910

10.  Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.

Authors:  Jonathan D Rohrer; Jennifer M Nicholas; David M Cash; John van Swieten; Elise Dopper; Lize Jiskoot; Rick van Minkelen; Serge A Rombouts; M Jorge Cardoso; Shona Clegg; Miklos Espak; Simon Mead; David L Thomas; Enrico De Vita; Mario Masellis; Sandra E Black; Morris Freedman; Ron Keren; Bradley J MacIntosh; Ekaterina Rogaeva; David Tang-Wai; Maria Carmela Tartaglia; Robert Laforce; Fabrizio Tagliavini; Pietro Tiraboschi; Veronica Redaelli; Sara Prioni; Marina Grisoli; Barbara Borroni; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Andrea Arighi; Giorgio Fumagalli; James B Rowe; Ian Coyle-Gilchrist; Caroline Graff; Marie Fallström; Vesna Jelic; Anne Kinhult Ståhlbom; Christin Andersson; Håkan Thonberg; Lena Lilius; Giovanni B Frisoni; Michela Pievani; Martina Bocchetta; Luisa Benussi; Roberta Ghidoni; Elizabeth Finger; Sandro Sorbi; Benedetta Nacmias; Gemma Lombardi; Cristina Polito; Jason D Warren; Sebastien Ourselin; Nick C Fox; Martin N Rossor; Giuliano Binetti
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.